Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 3
2006 4
2007 5
2008 3
2009 3
2010 8
2011 7
2012 5
2013 3
2014 5
2015 7
2016 6
2017 6
2018 5
2019 6
2020 9
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Kapoor R, et al. Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12. Lancet Neurol. 2018. PMID: 29545067 Clinical Trial.
Weak at the knees.
Kramarz C, Hayat T, Gran B. Kramarz C, et al. Among authors: gran b. Pract Neurol. 2022 Jan 13:practneurol-2021-003190. doi: 10.1136/practneurol-2021-003190. Online ahead of print. Pract Neurol. 2022. PMID: 35027458 No abstract available.
Fatigue in multiple sclerosis - a brief review.
Induruwa I, Constantinescu CS, Gran B. Induruwa I, et al. Among authors: gran b. J Neurol Sci. 2012 Dec 15;323(1-2):9-15. doi: 10.1016/j.jns.2012.08.007. Epub 2012 Aug 27. J Neurol Sci. 2012. PMID: 22935407 Review.
TLR2: an innate immune checkpoint in multiple sclerosis.
Hossain MJ, Tanasescu R, Gran B. Hossain MJ, et al. Among authors: gran b. Oncotarget. 2015 Nov 3;6(34):35131-2. doi: 10.18632/oncotarget.6031. Oncotarget. 2015. PMID: 26459385 Free PMC article. No abstract available.
84 results